Featured Attorney

Grant W. Hollingsworth

Associate

Grant W. Hollingsworth practices in the Firm's Complex Litigation, Toxic Torts & Products Liability, and Government Investigations groups, with his current core clients consisting of chemical and drug manufacturers. Read More >

Search Hollingsworth LLP's opinions from across the country. >

Precedents

• The Zometa® Cases

  Hollingsworth LLP outwits well-funded plaintiffs' attorney group by prevailing in early trials (including plaintiffs' trial picks) in consolidated litigation for client Novartis Pharmaceuticals Corporation.

• The Parlodel® Trilogy

  11th Circuit affirmance in Rider v. Sandoz Pharmaceuticals completes circuit court Daubert sweep in Parlodel® litigation.

• Favorable settlement reached for Norfolk Southern in largest single tort case in South Carolina history

  Avondale Mills, Inc. v. Norfolk Southern Corp., Civ. No. 1:05-2817-MBS (D.S.C. 2008)

• Court dismissed $4B claim brought by the State of New Mexico against Firm client General Electric.

  New Mexico v. Gen. Electric Co., 467 F.3d 1223 (10th Cir. 2006)

• Federal court grants Daubert and summary judgment motions filed by Firm client General Motors in PCB lawsuit.

  Allgood v. General Motors Corp., No. 1:02-cv-1077-DFH-TAB (S.D. Ind. Sept. 18, 2006)

Verdicts & Opinions

• Louisiana court grants summary judgment for SABIC Petrochemicals “from the bench” following oral argument.

  Bateast v. The Williams Co., Inc., No. 110,312 (La. 23rd Jud. Dist. Ct.) and Mitchell v. Williams Energy Partners, LP, No. 110,285 (La. 23rd Jud. Dist. Ct.) (April 21, 2017)

• 11th Circuit Affirms Coverage for Ongoing “Work” Under Plain Reading of RPL “Completed Work” Exclusion.

  Liberty Surplus Ins. Corp. v. Norfolk Southern Railway Co., No. 7:14-cv-00142-HL (11th Cir., Apr. 4, 2017)

• Novartis obtains summary judgment based on Daubert exclusion of causation experts’ testimony in Reclast® case.

  Jones v. Novartis Pharm. Corp., No. 2:13-cv-00624-VEH, slip op. (N.D. Ala. Feb. 10, 2017)

• Novartis obtains Daubert exclusion of causation experts’ testimony in Reclast® case.

  Jones v. Novartis Pharm. Corp., No. 2:13-cv-00624-VEH, slip op. (N.D. Ala. Jan. 26, 2017)

• Novartis obtains dismissal of Zometa case based on lack of proximate causation.

  Bock v. Novartis Pharm. Corp., Case No. 15-3696, slip op. at 1 (3d Cir. Oct. 5, 2016)